CSIR in the news..

An aggregation of news on the web about CSIR and its laboratories

Archive for the ‘IMTECH’ Category

IMTECH celebrates CSIR’s foundation day

27 September 2015

CHANDIGARH: IMTECH, CSIR The Institute of Microbial Technology (IMTECH), Chandigarh, celebrated Council of Scientific and Industrial Research’s foundation day on Saturday by organizing several events including a lecture by Dr Rajesh S Gokhale, director of CSIR-Institute of Genomics and Integrative Biology, Delhi.

Speaking on “Science, Medicine and Respectful Insolence”, Gokhale said that the fruits of applying science to medicine, something that really didn’t happen in a big way until around 150 years ago, have markedly extended the life expectancy of humans…..


Written by csirindia

September 27, 2015 at 10:16 pm

Posted in IMTECH

Novel Indian clotbuster

A new thrombolytic treatment discovered in India is poised to enter clinical trials following local authorities’ go-ahead on 17 August 2012. The home-grown clot-dissolving therapeutic could become the first innovative compound from an Indian public institute jointly developed with a US company. The drug, clot-specific streptokinase (CSSK), was developed by Girish…

Read more: http://www.nature.com/nbt/journal/v30/n10/full/nbt1012-903b.html

Written by csirindia

October 15, 2012 at 9:50 am

Posted in IMTECH

CSIR’s foundation day celebrated

26 September 2012

CHANDIGARH: The Institute of Microbial Technology (IMTECH) celebrated the foundation day of Central Scientific Institute of Research (CSIR), New Delhi, on Tuesday.

A lecture was delivered by prof Hans-Peter Klenk, head of department of microbiology, DSMZ-German Collection of Microorganisms & Cell Cultures, Germany. Prof Klenk spoke on “Classification of Bacteria and Archaea – from the beginning of microbiology to modern genome-based methods”……..

Read more: http://timesofindia.indiatimes.com/city/chandigarh/CSIRs-foundation-day-celebrated/articleshow/16551395.cms

Written by csirindia

September 27, 2012 at 11:45 am

Posted in IMTECH

Tummy worms affect TB vaccine

11 September 2012

HYDERABAD: The age-old advice to regularly get children and adults dewormed has now got some solid scientific backing. An Indian research team have found that the presence of worms in the stomach makes tuberculosis vaccinations relatively ineffective.

……….Scientists from the Institute of Microbial Technology, Chandigarh, said infections with parasitic worms interfere with the BCG vaccine and render it less effective. The research report, highlighting reasons for the failure of the BCG vaccine was published in the latest issue of scientific journal Trends in Molecular Medicine…….

Read more: http://www.deccanchronicle.com/channels/cities/hyderabad/tummy-worms-affect-tb-vaccine-123

Written by csirindia

September 19, 2012 at 9:40 am

Posted in IMTECH

Scientists make case for new TB vaccines

29 August 2012

Researchers with the CSIR-Institute of Microbial Technology in Chandigarh, India, published a review on Tuesday of the ineffectiveness of the Bacillus Calmette-Guerin tuberculosis vaccine and the proposed use of lipidated-promiscuous-peptide vaccines….

Read more: http://vaccinenewsdaily.com/medical_countermeasures/319771-scientists-make-case-for-new-tb-vaccines/

Written by csirindia

August 30, 2012 at 4:34 pm

Posted in IMTECH

Synthetic tuberculosis vaccines could save millions of lives

29 August 2012


Cases of one of the world’s deadliest diseases-tuberculosis-are spiralling at an alarming rate, due to the ineffectiveness of the existing vaccines, a new study including an Indian-origin researcher has revealed.

“Tuberculosis is a global health threat, and it is a highly communicable disease that may influence practically anyone and everyone,” says senior author Javed Agrewala of the CSIR-Institute of Microbial Technology in Chandigarh, India……

Read more: http://truthdive.com/2012/08/29/Synthetic-tuberculosis-vaccines-could-save-millions-of-lives.html

Written by csirindia

August 30, 2012 at 4:29 pm

Posted in IMTECH

Phase 1 trial of CSIR-IMTECH’s clot buster to start by end October

21 August 2012

The Institute of Microbial Technology (IMTECH), one of the national laboratories of the Council of Scientific & Industrial Research (CSIR) which recently received the Drugs Controller General of India (DCGI)’s nod for phase 1 trials for its clot buster drug is due to kick off the trial by end October at Veeda Clinical Research (Veeda CR), an Ahmedabad-headquartered CRO…..

Read more: http://www.expresspharmaonline.com/latest-updates/929-phase-1-trial-of-csir-imtech-s-clot-buster-to-start-by-end-october

Written by csirindia

August 22, 2012 at 11:48 am

Posted in IMTECH